Abstract
Influenza is a highly contagious, acute upper respiratory tract disease caused by influenza virus, a member of the Orthomyxoviridae family. The viral particles have two surface antigens, haemagglutinin and sialidase (neuraminidase) that extensively decorate the surface of the virus and have been implicated in viral attachment and fusion, and the release of virion progeny, respectively. The receptor for haemagglutinin is the terminal sialic acid residue of host cell surface sialyloligosaccharides, while sialidase catalyses the hydrolysis of terminal sialic acid residues from sialyloligosaccharides. Extensive crystallographic studies of both these proteins have revealed that the residues that interact with the sialic acid are strictly conserved. Therefore, these proteins make attractive targets for the design of drugs to halt the progression of the virus. Recent successful efforts in the search for new cures for influenza have led to the development of three clinically-useful anti-influenza drugs. All three are potent, selective inhibitors of influenza virus A and B sialidase. Strategies for the development of haemagglutinin inhibitors have also been devised.
Keywords: anti-influenza therapies, Influenza, influenza virus, haemagglutinin inhibitors
Current Drug Targets
Title: Recent Strategies in the Search for New Anti-Influenza Therapies
Volume: 4 Issue: 5
Author(s): J. C. Wilson and M. von Itzstein
Affiliation:
Keywords: anti-influenza therapies, Influenza, influenza virus, haemagglutinin inhibitors
Abstract: Influenza is a highly contagious, acute upper respiratory tract disease caused by influenza virus, a member of the Orthomyxoviridae family. The viral particles have two surface antigens, haemagglutinin and sialidase (neuraminidase) that extensively decorate the surface of the virus and have been implicated in viral attachment and fusion, and the release of virion progeny, respectively. The receptor for haemagglutinin is the terminal sialic acid residue of host cell surface sialyloligosaccharides, while sialidase catalyses the hydrolysis of terminal sialic acid residues from sialyloligosaccharides. Extensive crystallographic studies of both these proteins have revealed that the residues that interact with the sialic acid are strictly conserved. Therefore, these proteins make attractive targets for the design of drugs to halt the progression of the virus. Recent successful efforts in the search for new cures for influenza have led to the development of three clinically-useful anti-influenza drugs. All three are potent, selective inhibitors of influenza virus A and B sialidase. Strategies for the development of haemagglutinin inhibitors have also been devised.
Export Options
About this article
Cite this article as:
Wilson C. J. and Itzstein von M., Recent Strategies in the Search for New Anti-Influenza Therapies, Current Drug Targets 2003; 4 (5) . https://dx.doi.org/10.2174/1389450033491019
DOI https://dx.doi.org/10.2174/1389450033491019 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19:
Case Series from Iran
Infectious Disorders - Drug Targets History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
Coronaviruses Determination of Binding Potential of HCV Protease Inhibitors Against to SARS-CoV-2 Papain-like Protease wtih Computational Docking
Letters in Drug Design & Discovery Accommodating Protein Flexibility for Structure-Based Drug Design
Current Topics in Medicinal Chemistry A Systematic Review on the Sinomenine Derivatives
Mini-Reviews in Medicinal Chemistry Unraveling the Structure and Function of G Protein-Coupled Receptors Through NMR Spectroscopy
Current Pharmaceutical Design Traumatic Stress Reactions in Parents in Pediatric Intensive Care: A Review
Current Psychiatry Reviews On the Psychotropic Effects of Carbon Dioxide
Current Pharmaceutical Design Docking-Based Virtual Screening: Recent Developments
Combinatorial Chemistry & High Throughput Screening Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Facile Synthesis and Biological Evaluation of New Mannich Products as Potential Antibacterial, Antifungal and Antituberculosis Agents: Molecular Docking Study
Current Bioactive Compounds MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
Current Pharmaceutical Design The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design New Strategies for Immune-Mediated Anti-Viral Drug and Vaccine Development
Current Pharmaceutical Design Design and Synthesis of Dopaminergic Agonists
Current Medicinal Chemistry Understanding the Dynamics of COVID-19 Outbreak: Structure, Diagnosis, Prevention and Treatment
Anti-Infective Agents A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses
Anti-Infective Agents Mutilins Derivatives: From Veterinary to Human-used Antibiotics
Mini-Reviews in Medicinal Chemistry Current Overviews on COVID-19 Management Strategies
Current Pharmaceutical Biotechnology Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets